ViCentra has appointed Reman McDonagh as Vice President, Global Marketing.
ViCentra specialises in diabetes care and medical device commercialisation, and Reman brings over two decades of experience to her new role. She most recently held multiple senior leadership roles in marketing at Insulet, a medical device company developing products for people with diabetes. During this time, Reman took responsibility for the launch of the company’s Omnipod DASH in multiple European countries, as well as assisting with the launch strategy for Omnipod 5.
Reman has also held leadership roles at companies including Roche, Medtronic and Cellnovo. Her areas of expertise include brand strategy, market development and product launches.
Reman’s appointment will help to build on ViCentra’s growth to date, as the company continues with the commercialisation of the Kaleido insulin patch pump system. She will also drive European commercial execution and assist in preparations for EU and US launches.
The news follows a number of other senior commercial leadership appointments at ViCentra.
Tom Arnold, CEO of ViCentra, said: “Reman joins ViCentra at a pivotal stage as we transition from strong early traction to disciplined, scalable growth. She brings a rare combination of deep diabetes expertise, end-to-end marketing leadership and operational rigour, as we strengthen our presence in key European markets and prepare for US market entry.”
Reman added: “Kaleido is a truly differentiated insulin delivery system, and ViCentra has built meaningful momentum through a clear focus on the user experience.”